Volitionrx (VNRX) Total Debt Growth (1y) (2019 - 2025)
Volitionrx (VNRX) Total Debt Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn | 157.11% |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn | -12.26% |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | -2.48% |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn | 0.12% |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | -5.76% |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - | -2.49% |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn | 19.06% |
| 10 | Volitionrx | 90,883.07 | -1.03 Mn | - | 39.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 39.39% |
| Sep 30, 2025 | 12.33% |
| Jun 30, 2025 | 59.03% |
| Mar 31, 2025 | 60.47% |
| Dec 31, 2024 | -0.39% |
| Sep 30, 2024 | 72.47% |
| Jun 30, 2024 | 1.18% |
| Mar 31, 2024 | 23.22% |
| Dec 31, 2023 | 25.64% |
| Sep 30, 2023 | 0.14% |
| Jun 30, 2023 | 71.52% |
| Mar 31, 2023 | 9.06% |
| Dec 31, 2022 | 25.33% |
| Sep 30, 2022 | 19.82% |
| Jun 30, 2022 | -26.81% |
| Dec 31, 2021 | -11.01% |
| Dec 31, 2020 | 21.29% |
| Dec 31, 2019 | 18.41% |